SARASOTA, FL -- (MARKET WIRE) -- November 01, 2006 -- DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that Biofrontera A.G., in which the Company now holds an approximate 10% stake, commenced the co-listing of its common stock yesterday under the symbol B8F on the Frankfurter Wertpapierbörse (Frankfurt Stock Exchange), finishing the trading day at EUR 15.19 (approximately $19.29 US).
